All News
Filter News
Found 808,690 articles
-
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of its First-Ever CBD Gel Capsules
8/30/2018
SAN DIEGO, /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary Dixie Botanicals® has released new cannabidiol (CBD) gel capsules, the first of their kind for the company.
-
Electromed, Inc. Schedules Release of Fourth Quarter Fiscal 2018 Financial Results and Conference Call
8/30/2018
Electromed, Inc., (NYSE American:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2018 fourth quarter ended June 30, 2018 on Tuesday, September 25, 2018 after the close of the stock market.
-
SKB (SAKURA BLOOM) virtual currency announces use of SKB token for Regenerative Medicine
8/30/2018
We have developed a revolutionary program that allows SKB token users to access state-of-the-art Regenerative Medicine technology," said Takakazu Hirono, President of NEGTEC Co., Ltd. and founder of cryptocurrency SAKURA BLOOM (SKB).
-
Olympic Sports Therapist Says Your Posture May Be Making You Fat
8/30/2018
he U.S. weight loss market is now worth a record $66 billion, but the number of dieters has fallen, due to the growth of the size acceptance and body positivity movement. Do-it-yourself plans still abound as consumers use more diet & fitness apps.
-
Akebia Therapeutics to Participate in Upcoming Investor Conferences
8/30/2018
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will participate in the following investor conferences: The
-
ArQule to Participate in Citi’s 13th Annual Biotech Conference on September 6, 2018
8/30/2018
ArQule, Inc., (Nasdaq: ARQL) today announced that Paolo Pucci, CEO, Peter Lawrence, President and COO, Brian Schwartz, CMO and Head of R&D and Marc Schegerin, Senior Vice President and Head of Strategy, Finance and Communication, will participate in Citi’s 13th Annual Biotech Conference on September 6, 2018, at the Four Seasons Hotel in Boston, MA.
-
BioPharmX Reports Second Quarter 2019 Financial Results
8/30/2018
BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today reports financial results for the quarter ended July 31, 2018.
-
Kewaunee Scientific Corporation Promotes Lisa L. Ryan
8/30/2018
Kewaunee Scientific Corporation (Nasdaq: KEQU) announced that the Company's Board of Directors promoted Lisa L. Ryan to Vice President of Construction and Customer Operations.
-
vTv Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
8/30/2018
vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer’s disease and diabetes, today announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference,
-
Homology Medicines to Participate in Gene Editing Panel at Citi's Biotech Conference
8/30/2018
Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will participate in a panel on gene editing during Citi's 13th Annual Biotech Conference at 1:15 p.m. ET on Wednesday, September 5th at the Four Seasons in Boston.
-
Timicoin/TimiHealth Urges Consumers to Petition 23andMe and Other Genetic Testing Companies and Demand Ownership and Control of Their Genetic Data
8/30/2018
Timicoin/TimiHealth (www.timicoin.io), the leader in genetic data ownership through its ultra secureblockchain technology is urging consumers to petition genetic testing companies like 23andMe to provide complete transparency in how they use collected genetic data and allow portability to whomever individual consumers choose to have it.
-
Leap Therapeutics to Participate in the H.C. Wainwright 20th Annual Global Investment Conference
8/30/2018
Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 20th Annual Global Investment Conference,
-
Array BioPharma to Present at the Wells Fargo Securities 2018 Healthcare Conference
8/30/2018
Array BioPharma, Inc. Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Wells Fargo Securities 2018 Healthcare Conference in Boston.
-
Synthetic Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
8/30/2018
Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that Steven A. Shallcross, Interim Chief Executive Officer & Chief Financial Officer, will present a corporate overview at the 20th Annual Rodman & Renshaw Global
-
Accreditation Council Appoints Pharma Power Players, former Otsuka CEO, Bob Oliver and Astellas Executive, S. Bob Chib to its Board of Governors.
8/30/2018
Accreditation Council for Medical Affairs (ACMA), an independent, self-governing organization whose mission is to promote standards of excellence around technical competencies and ethical practices for pharmaceutical industry professionals in medical & scientific affairs, has appointed two power players to its Board of Governors.
-
Dr. Briggs Cook Scholarship Program for Health & Sciences
8/30/2018
Founder and Director of Pure Facial Plastic Surgery & Medspa in Huntersville, North Carolina, Dr. Briggs Cook is excited to announce two scholarships valued at $500.00 (CAD/USD) available to students pursuing a career in childcare, health or life sciences, medicine, nursing, or psychology.
-
Edwards Lifesciences To Present At The 13th Annual Wells Fargo Healthcare Conference
8/30/2018
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the 13th Annual Wells Fargo Healthcare Conference at the Westin Copley Place in Boston, Massachusetts on Thursday, September 6, 2018.
-
ORIC to Participate at Citi 13th Annual Biotech Investor Conference
8/30/2018
ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, announced today that it will be participating in Citi's 13th Annual Biotech Conference in Boston on September 5th
-
Cerus to Present at the Baird 2018 Global Healthcare Conference
8/30/2018
Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ vice president, finance and chief financial officer, will present and provide a corporate update at the Baird 2018 Global Healthcare Conference in New York City on Thursday, September 6, 2018 at 8:30 a.m. ET.
-
Hyatt and Sutherland to Use pymetrics Platform to Hire Thousands of Opportunity Youth
8/30/2018
pymetrics, a New York City-based company that uses neuroscience and AI to predict the right person for a job while removing bias from the process, today announced the corporate partners who will participate in an initiative supported by a $150,000 grant from The Rockefeller Foundation